Antibiotic consumption at 46 VINCat hospitals from 2007 to 2009, stratified by hospital size and clinical services

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 30, Issue SUPPL. 3, 2012, Pages 43-51

  Grau, Santiago ^a   Fondevilla, Esther ^b   Mojal, Sergi ^c   Palomar, Mercedes ^d   Vallès, Jordi ^e   Gudiol, Francesc ^f  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Servei Català de la Salut   (Spain)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL DE SABADELL   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Antibiotic consumption; DDD; Nationwide study

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFTRIAXONE; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DAPTOMYCIN; FOSFOMYCIN; LEVOFLOXACIN; MONOBACTAM; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLONE DERIVATIVE; TIGECYCLINE;

ARTICLE; DRUG USE; EMERGENCY CARE; HOSPITAL BED CAPACITY; HOSPITAL DEPARTMENT; HOSPITAL ORGANIZATION; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE UNIT; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; HOSPITAL BED CAPACITY; HOSPITAL DEPARTMENTS; HOSPITALS, PUBLIC; HOSPITALS, UNIVERSITY; HUMANS; RETROSPECTIVE STUDIES; SPAIN;

EID: 84863612424     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(12)70096-4     Document Type: Article

References (23)

1. S. Mölstad, O. Cars, and J. Struwe Strama: a Swedish working model for containment of antibiotic resistance Euro Surveill 13 2008 pii=19041
2. H.A. Verbrugh Mapping antibiotic use and resistance in the Netherlands: SWAB and NethMap Neth J Med 61 2003 341 342
3. F. Bager DANMAP: monitoring antimicrobial resistance in Denmark Int J Antimicrob Agents 14 2000 271 274 (Pubitemid 30224488)
4. C. Dumartin, F. L'Hériteau, M. Péfau, X. Bertrand, P. Jarno, and S. Boussat Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007 J Antimicrob Chemother 65 2010 2028 2036
5. RAISIN Working Group RAISIN: a national programme for early warning, investigation and surveillance of healthcare-associated infection in France Euro Surveill 14 2009 pii=19408
6. NORM/NORM-VET 2009. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Tromso /Oslo; 2010. Available in: http://www.vetinst.no/eng/Research/Publications/Norm-Norm-Vet-Report (14 July 2011, date last accessed).
7. HSE-HPSC. Consumption of Antibiotics in Public Acute Hospitals in Ireland. 2010 Data. Available in: http://www.hpsc.ie/hpsc/A-Z/ MicrobiologyAntimicrobialResistance/ EuropeanSurveillanceofAntimicrobialConsumptionESAC/SurveillanceReports/File, 4361,en.pdf (7 June 2012, date last accessed).
8. R.H. Vander Stichele, M.M. Elseviers, M. Ferech, S. Blot, H. Goossens European Survaillance of Antibiotic Comsuption (ESAC) Project Group. et al Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002) J Antimicrob Chemother 58 2006 159 167 (Pubitemid 44295000)
9. F. Ansari, H. Molana, H. Goossens, and P. Davey Development of standardized methods for analysis of changes in antibiotic use in hospitals from 18 European countries:the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000-06 J Antimicrob Chemother 65 2010 2685 2691
10. VINCat Program. Available in: http://www.vincat.gencat.cat (14 July 2011, date last accessed).
11. th ed. Oslo, 2010.
12. ® Excel application]. Version 3.1. Copenhagen (Denmark): Statens Serum Institut; 2006. Available in: http://www.escmid.org/fileadmin/src/media/ PDFs/3Research-Projects/ESGAP/ABC-Calc-3.1-b.xls (14 July 2011, date last accessed).
13. WHO Collaborating Centre for Drug Statistics Methodology. ATC Index with DDDs. Available in: https://www.whocc.no/ (14 July 2011, date last accessed).
14. DANMAP 2009. Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Foods and Humans in Denmark. Available in: http://www.danmap.org/pdfFiles/Danmap-2009.pdf (14 July 2011, date last accessed).
15. SWAB. NETHMAP 2011. Consumption of Antimicrobial Agents and Antimicrobial Resistance among Medically Important Bacteria in the Netherlands. Available in: http://www.swab.nl/swab/cms3.nsf/uploads/35ACD3A546C31716C12578BF002EDC4F/ $FILE/NethMap2011.pdf (14 July 2011, date last accessed).
16. C. Plüss-Suard, A. Pannatier, A. Kronenberg, K. Mühlemann, and G. Zanetti Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe J Hosp Infect 79 2011 166 171
17. SWEDRES 2010. A Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine. Available in: http://www.smittskyddsinstitutet.se/upload/ Publikationer/swedres-2010.pdf (14 July 2011, date last accessed).
18. F. Scaglione, and L. Paraboni Pharmacokinetics/pharmacodynamics of antibiotics in the intensive care unit: setting appropriate dosing regimens Int J Antimicrob Agents 32 2008 294 301
19. E. Meyer, F. Schwab, B. Schroeren-Boersch, and P. Gastmeier Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008 Crit Care 14 2010 R113
20. H. Wunsch, D.C. Angus, D.A. Harrison, O. Collange, R. Fowler, and E.A. Hoste Variation in critical care services across North America and Western Europe Crit Care Med 36 2008 2787 2793
21. R. Benkö, M. Matuz, Z. Petö, L. Bogár, R. Viola, and P. Doró Variations and determinants of antibiotic consumption in Hungarian adult intensive care units Pharmacoepidemiol Drug Saf 21 2012 104 109
22. S.P. Kuster, C. Ruef, A.K. Bollinger, B. Ledergerber, A. Hintermann, and C. Deplazes Correlation between case mix index and antibiotic use in hospitals J Antimicrob Chemother 62 2008 837 842
23. P.M.G. Filius, T.B.Y. Liem, and P.D. Van der Linden An additional measure for quantifying antibiotic use in hospitals J Antimicrob Chemother 55 2005 805 808 (Pubitemid 40691868)